UK and German device safety notices: what QA can and can't learn from the public lists
MHRA listed eight field safety notices for 9–13 November while BfArM posted six more. Public entries say little, so the real work happens in your own vigilance and supplier-control processes.
What happened
On 17 November 2026 the MHRA published its weekly list of device Field Safety Notices (FSNs) for 9–13 November. It contains eight notices. The manufacturers named include Boston Scientific, Brainlab, Medtronic, Siemens Healthcare and Ortho-Clinical Diagnostics. The MHRA publishes the list for information only. The records do not say which products the eight notices cover or what problems they describe.
Germany's BfArM was active in the same days. On 16 and 17 November it posted six urgent field safety notices: Philips (IntraSight Plus ultrasound system), Medtronic (Vanta implantable neurostimulator), Arthrex (NanoNeedle Scope), Urovision (VISIO-WEB WEBSINGER catheter), Intelerad (InteleShare imaging software) and Hitachi (cobas c 303 clinical chemistry analyser). In each case the public entry points to the manufacturer's own advisory, or gives no detail on the problem or required actions.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Sources this analysis is based on
- MHRA lists eight device Field Safety Notices in weekly update for 9–13 November MHRA alerts · Tue 17 Nov 2026
- Health Canada flags foreign matter in four lots of Pendopharm's PegLyte Powder Health Canada · Tue 17 Nov 2026
- BfArM lists Arthrex field safety notice for NanoNeedle Scope BfArM field safety notices · Tue 17 Nov 2026
- BfArM publishes Urovision urgent field safety notice for VISIO-WEB WEBSINGER catheter BfArM field safety notices · Tue 17 Nov 2026
- BfArM publishes Intelerad field safety notice for InteleShare imaging software BfArM field safety notices · Tue 17 Nov 2026
- BfArM lists urgent field safety notice for Hitachi cobas c 303 analytical unit BfArM field safety notices · Tue 17 Nov 2026
Written by VigiEye's editorial system with AI assistance (model claude-sonnet-5-5) strictly from the official records listed above. It can contain errors: check the sources before acting. Not legal, medical or investment advice.
Tablo power cord overheating alert shows how a simple instruction change becomes a PV control
FDA's early alert on Outset Medical's Tablo cords is a reminder that use-instruction updates depend on reporting, user follow-through and a clear view of what is still unknown.
Lantern Pharma's first TNBC site and Taiwan start meet a CEO exit and a $4.0M raise
Lantern Pharma reported trial milestones for LP-184 and LP-300 in the same release as a CEO resignation and a roughly $4.0M offering, a mix sponsors and CROs should read carefully.
EEA Decision 191/2026 extends six EU feed additive acts to EEA EFTA markets, minus Liechtenstein
The EEA Joint Committee has added six feed additive acts, including a monensin sodium renewal and a Duddingtonia flagrans approval, to Annex I. Market access teams should read it as a lesson in how EU rules reach EEA markets.